Market Exclusive

CME GROUP INC. (NASDAQ:CME) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

CME GROUP INC. (NASDAQ:CME) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May8, 2018, the Compensation Committee of the Board of Directors (the “Board”) of CME Group Inc. (the “Company”) recommended and the Board approved an amended and restated employment agreement (the “Amended Agreement”) with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer, which extends Mr.Duffy’s current term from December31, 2020 to December31, 2022 on substantially the same terms as his existing agreement. No changes were made to Mr.Duffy’s minimum annual base salary, target bonus opportunity or target grant date value opportunity. Under the Amended Agreement, if Mr.Duffy is employed by the Company on December31, 2022, (i) Mr.Duffy will be entitled to a bonus opportunity under the Company’s incentive plan for the 2022 plan year (without any requirement to remain employed after such date), and (ii)all outstanding unvested time-vesting equity awards granted to Mr.Duffy after December31, 2020 will vest and all of Mr.Duffy’s performance-based equity awards granted during such period shall become vested or be forfeited solely based on actual performance measured over the full performance term, which bonus award and vesting are subject to Mr.Duffy’s timely execution and delivery of a general release.

The foregoing description is only a summary of certain terms of the Amended Agreement and is qualified in its entirety by the complete text of the Amended Agreement, which is attached to this report as Exhibit 10.1 and is incorporated herein by reference as though fully set forth herein.

Item 5.02 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number

Description

10.1 Amended and Restated Agreement, effective as of May8, 2018, by and between CME Group Inc. and Terrence A. Duffy

EXHIBITINDEX

CME GROUP INC. ExhibitEX-10.1 2 d576588dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 AMENDED AND RESTATED AGREEMENT THIS AMENDED AND RESTATED AGREEMENT,…To view the full exhibit click here
About CME GROUP INC. (NASDAQ:CME)
CME Group Inc. is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City. Its CME Direct technology offers side-by-side trading of exchange-listed and privately negotiated markets. The Company provides clearing and settlement services for exchange-traded contracts, as well as for cleared swaps, and provides regulatory reporting solutions for market participants through its global repository services in the United States, United Kingdom, Canada and Australia. It offers a range of market data services, including live quotes, delayed quotes, market reports and a historical data service.

Exit mobile version